These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 16258214)
21. Immunoglobulin light (heavy)-chain deposition disease: from molecular medicine to pathophysiology-driven therapy. Ronco P; Plaisier E; Mougenot B; Aucouturier P Clin J Am Soc Nephrol; 2006 Nov; 1(6):1342-50. PubMed ID: 17699367 [TBL] [Abstract][Full Text] [Related]
22. Long-term renal survival of γ3-heavy chain deposition disease: a case report. Katsuno T; Mizuno S; Mabuchi M; Tsuboi N; Komatsuda A; Maruyama S BMC Nephrol; 2017 Jul; 18(1):239. PubMed ID: 28716013 [TBL] [Abstract][Full Text] [Related]
23. Immunophenotypic analysis of abnormal plasma cell clones in bone marrow of primary systemic light chain amyloidosis patients. Hu Y; Wang M; Chen Y; Chen X; Fang F; Liu S; Zhang Y; Wu X; Zhu P Chin Med J (Engl); 2014; 127(15):2765-70. PubMed ID: 25146610 [TBL] [Abstract][Full Text] [Related]
24. The significance of light chain-restricted bone marrow plasma cells after peripheral blood stem cell transplantation for multiple myeloma. Maia DM; Kell DL; Goates JJ; Warnke RA Am J Clin Pathol; 1997 Jun; 107(6):643-52. PubMed ID: 9169660 [TBL] [Abstract][Full Text] [Related]
25. Mechanisms of disease: monoclonal immunoglobulin deposition. Amyloidosis, light chain deposition disease, and light and heavy chain deposition disease. Buxbaum J Hematol Oncol Clin North Am; 1992 Apr; 6(2):323-46. PubMed ID: 1582976 [TBL] [Abstract][Full Text] [Related]
26. Reversal of dialysis-dependent renal failure in light-chain deposition disease by autologous peripheral blood stem cell transplantation. Firkin F; Hill PA; Dwyer K; Gock H Am J Kidney Dis; 2004 Sep; 44(3):551-5. PubMed ID: 15332228 [TBL] [Abstract][Full Text] [Related]
27. Rapid reversal of nephrotic syndrome due to primary systemic AL amyloidosis after VAD and subsequent high-dose chemotherapy with autologous stem cell support. Sezer O; Schmid P; Shweigert M; Heider U; Eucker J; Harder H; Sinha P; Radtke H; Possinger K Bone Marrow Transplant; 1999 May; 23(9):967-9. PubMed ID: 10338056 [TBL] [Abstract][Full Text] [Related]
28. [Detection of monoclonal plasma cells in bone marrow and spleen of primary amyloidosis]. Katayama Y; Sakai A; Nobuyoshi M; Shimomura T; Kimura A Rinsho Ketsueki; 2001 Sep; 42(9):705-9. PubMed ID: 11680983 [TBL] [Abstract][Full Text] [Related]
32. Use of bortezomib in heavy-chain deposition disease: a report of 3 cases. Patel K; Dillon JJ; Leung N; Bomback AS; Appel GB; D'Agati V; Canetta PA Am J Kidney Dis; 2014 Jul; 64(1):123-7. PubMed ID: 24613055 [TBL] [Abstract][Full Text] [Related]
33. [More than 10 years of complete remission of monoclonal gammopathy of undetermined significance and cessation of light chain deposition disease-associated nephrotic syndrome following treatment with vincristine, adriamycin and high-dose dexamethasone (VAD)]. Adam Z; Nedbálková M; Krejcí M; Pour L; Husek K; Veselý K; Cermáková Z; Krivanová A; Mayer J; Hájek R Vnitr Lek; 2010 Mar; 56(3):240-6. PubMed ID: 20394211 [TBL] [Abstract][Full Text] [Related]